Global Sorafenib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Sorafenib Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Capsule
  • 1.2.2 Tablet
• 1.3 Market Analysis by Applications
  • 1.3.1 Hospital Pharmacy
  • 1.3.2 Retail Pharmacy
  • 1.3.3 Online Pharmacy
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2014-2024)
    • 1.4.1.2 Canada Market States and Outlook (2014-2024)
    • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2014-2024)
    • 1.4.2.2 France Market States and Outlook (2014-2024)
    • 1.4.2.3 UK Market States and Outlook (2014-2024)
    • 1.4.2.4 Russia Market States and Outlook (2014-2024)
    • 1.4.2.5 Italy Market States and Outlook (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2014-2024)
    • 1.4.3.2 Japan Market States and Outlook (2014-2024)
    • 1.4.3.3 Korea Market States and Outlook (2014-2024)
    • 1.4.3.4 India Market States and Outlook (2014-2024)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
    • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
    • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Pfizer
  • 2.1.1 Business Overview
  • 2.1.2 Sorafenib Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Pfizer Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Allergan
  • 2.2.1 Business Overview
  • 2.2.2 Sorafenib Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Allergan Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Alnylam Pharmaceuticals
  • 2.3.1 Business Overview
  • 2.3.2 Sorafenib Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Acceleron Pharma
  • 2.4.1 Business Overview
  • 2.4.2 Sorafenib Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Acceleron Pharma Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Biocon
  • 2.5.1 Business Overview
  • 2.5.2 Sorafenib Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Biocon Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Bionomics
  • 2.6.1 Business Overview
  • 2.6.2 Sorafenib Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Bionomics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 CASI Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Sorafenib Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 CASI Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Celgene Corporation
  • 2.8.1 Business Overview
  • 2.8.2 Sorafenib Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Celgene Corporation Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Enzon Pharmaceuticals
  • 2.9.1 Business Overview
  • 2.9.2 Sorafenib Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Enzon Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Five Prime Therapeutics
  • 2.10.1 Business Overview
  • 2.10.2 Sorafenib Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Five Prime Therapeutics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Fujifilm Kyowa Kirin Biologics
  • 2.11.1 Business Overview
  • 2.11.2 Sorafenib Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Fujifilm Kyowa Kirin Biologics Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Genentech
  • 2.12.1 Business Overview
  • 2.12.2 Sorafenib Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Genentech Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Genexine
  • 2.13.1 Business Overview
  • 2.13.2 Sorafenib Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Genexine Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Hetero Drugs
  • 2.14.1 Business Overview
  • 2.14.2 Sorafenib Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Hetero Drugs Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 ImClone Systems
  • 2.15.1 Business Overview
  • 2.15.2 Sorafenib Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 ImClone Systems Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Intas Pharmaceuticals
  • 2.16.1 Business Overview
  • 2.16.2 Sorafenib Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Intas Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 Levolta Pharmaceuticals
  • 2.17.1 Business Overview
  • 2.17.2 Sorafenib Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 Levolta Pharmaceuticals Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 Mabtech
  • 2.18.1 Business Overview
  • 2.18.2 Sorafenib Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 Mabtech Sorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Sorafenib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

• 3.1 Global Sorafenib Sales and Market Share by Manufacturer (2017-2018)
• 3.2 Global Sorafenib Revenue and Market Share by Manufacturer (2017-2018)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Sorafenib Manufacturer Market Share in 2018
  • 3.3.2 Top 6 Sorafenib Manufacturer Market Share in 2018
• 3.4 Market Competition Trend

4 Global Sorafenib Market Analysis by Regions

• 4.1 Global Sorafenib Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Sorafenib Sales and Market Share by Regions (2014-2019)
  • 4.1.2 Global Sorafenib Revenue and Market Share by Regions (2014-2019)
• 4.2 North America Sorafenib Sales and Growth Rate (2014-2019)
• 4.3 Europe Sorafenib Sales and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Sorafenib Sales and Growth Rate (2014-2019)
• 4.5 South America Sorafenib Sales and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Sorafenib Sales and Growth Rate (2014-2019)

5 North America Sorafenib by Country

• 5.1 North America Sorafenib Sales, Revenue and Market Share by Country
  • 5.1.1 North America Sorafenib Sales and Market Share by Country (2014-2019)
  • 5.1.2 North America Sorafenib Revenue and Market Share by Country (2014-2019)
• 5.2 United States Sorafenib Sales and Growth Rate (2014-2019)
• 5.3 Canada Sorafenib Sales and Growth Rate (2014-2019)
• 5.4 Mexico Sorafenib Sales and Growth Rate (2014-2019)

6 Europe Sorafenib by Country

• 6.1 Europe Sorafenib Sales, Revenue and Market Share by Country
  • 6.1.1 Europe Sorafenib Sales and Market Share by Country (2014-2019)
  • 6.1.2 Europe Sorafenib Revenue and Market Share by Country (2014-2019)
• 6.2 Germany Sorafenib Sales and Growth Rate (2014-2019)
• 6.3 UK Sorafenib Sales and Growth Rate (2014-2019)
• 6.4 France Sorafenib Sales and Growth Rate (2014-2019)
• 6.5 Russia Sorafenib Sales and Growth Rate (2014-2019)
• 6.6 Italy Sorafenib Sales and Growth Rate (2014-2019)

7 Asia-Pacific Sorafenib by Country

• 7.1 Asia-Pacific Sorafenib Sales, Revenue and Market Share by Country
  • 7.1.1 Asia-Pacific Sorafenib Sales and Market Share by Country (2014-2019)
  • 7.1.2 Asia-Pacific Sorafenib Revenue and Market Share by Country (2014-2019)
• 7.2 China Sorafenib Sales and Growth Rate (2014-2019)
• 7.3 Japan Sorafenib Sales and Growth Rate (2014-2019)
• 7.4 Korea Sorafenib Sales and Growth Rate (2014-2019)
• 7.5 India Sorafenib Sales and Growth Rate (2014-2019)
• 7.6 Southeast Asia Sorafenib Sales and Growth Rate (2014-2019)

8 South America Sorafenib by Country

• 8.1 South America Sorafenib Sales, Revenue and Market Share by Country
  • 8.1.1 South America Sorafenib Sales and Market Share by Country (2014-2019)
  • 8.1.2 South America Sorafenib Revenue and Market Share by Country (2014-2019)
• 8.2 Brazil Sorafenib Sales and Growth Rate (2014-2019)
• 8.3 Argentina Sorafenib Sales and Growth Rate (2014-2019)
• 8.4 Colombia Sorafenib Sales and Growth Rate (2014-2019)

9 Middle East and Africa Sorafenib by Countries

• 9.1 Middle East and Africa Sorafenib Sales, Revenue and Market Share by Country
  • 9.1.1 Middle East and Africa Sorafenib Sales and Market Share by Country (2014-2019)
  • 9.1.2 Middle East and Africa Sorafenib Revenue and Market Share by Country (2014-2019)
• 9.2 Saudi Arabia Sorafenib Sales and Growth Rate (2014-2019)
• 9.3 Turkey Sorafenib Sales and Growth Rate (2014-2019)
• 9.4 Egypt Sorafenib Sales and Growth Rate (2014-2019)
• 9.5 Nigeria Sorafenib Sales and Growth Rate (2014-2019)
• 9.6 South Africa Sorafenib Sales and Growth Rate (2014-2019)

10 Global Sorafenib Market Segment by Type

• 10.1 Global Sorafenib Sales, Revenue and Market Share by Type (2014-2019)
  • 10.1.1 Global Sorafenib Sales and Market Share by Type (2014-2019)
  • 10.1.2 Global Sorafenib Revenue and Market Share by Type (2014-2019)
• 10.2 Capsule Sales Growth and Price
  • 10.2.1 Global Capsule Sales Growth (2014-2019)
  • 10.2.2 Global Capsule Price (2014-2019)
• 10.3 Tablet Sales Growth and Price
  • 10.3.1 Global Tablet Sales Growth (2014-2019)
  • 10.3.2 Global Tablet Price (2014-2019)

11 Global Sorafenib Market Segment by Application

• 11.1 Global Sorafenib Sales Market Share by Application (2014-2019)
• 11.2 Hospital Pharmacy Sales Growth (2014-2019)
• 11.3 Retail Pharmacy Sales Growth (2014-2019)
• 11.4 Online Pharmacy Sales Growth (2014-2019)

12 Sorafenib Market Forecast (2019-2024)

• 12.1 Global Sorafenib Sales, Revenue and Growth Rate (2019-2024)
• 12.2 Sorafenib Market Forecast by Regions (2019-2024)
  • 12.2.1 North America Sorafenib Market Forecast (2019-2024)
  • 12.2.2 Europe Sorafenib Market Forecast (2019-2024)
  • 12.2.3 Asia-Pacific Sorafenib Market Forecast (2019-2024)
  • 12.2.4 South America Sorafenib Market Forecast (2019-2024)
  • 12.2.5 Middle East and Africa Sorafenib Market Forecast (2019-2024)
• 12.3 Sorafenib Market Forecast by Type (2019-2024)
  • 12.3.1 Global Sorafenib Sales Forecast by Type (2019-2024)
  • 12.3.2 Global Sorafenib Market Share Forecast by Type (2019-2024)
• 12.4 Sorafenib Market Forecast by Application (2019-2024)
  • 12.4.1 Global Sorafenib Sales Forecast by Application (2019-2024)
  • 12.4.2 Global Sorafenib Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology